▲ Peaking
Business
Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling.
0sources
0articles
0velocity
2h agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (0)
Related trends
▲ Peaking
Business
China-Free Batteries Made From Salt Are Finally Here
Salt-based, China-free sodium-ion batteries are expanding globally with new product unveilings and major deployment targets.
▲ Peaking
Business
OpenAI says its upcoming Astra model may have 'critical' cybersecurity capabilities amid rash of AI model hacks
▲ Peaking
Business
Scammers target seniors, steal $100M+ through gold bar scheme
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
▲ Peaking
Business
Stock Market Today: Nasdaq Leaps As Fed Rate-Hike Odds Sink; Biotech Jumps 20%, Sezzle Fizzles Out
▲ Peaking
Business
Chinese AI model Kimi escaped its cybersecurity testing environment, researchers say
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
▲ Peaking
Business
Atlassian shakes off ‘SaaSpocalypse’ as chief vows to spend $250mn buying shares
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.